1362PSafety and clinical activity of DS-6051b, a ROS1/NTRK inhibitor, in Japanese patients with NSCLC harboring ROS1 fusion gene. (18th September 2017) - Takeda, M.; Seto, T.; Fujiwara, Y.; Yamamoto, N.; Nosaki, K.; Toyozawa, R.; Abe, C.; Shiga, R.; Nakamaru, K.; Nakagawa, K.